Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Alto Neuroscience (ANRO) Accumulated Depreciation & Amortization (2023 - 2026)

Alto Neuroscience has reported Accumulated Depreciation & Amortization over the past 4 years, most recently at -$1.7 million for Q1 2026.

  • Quarterly results put Accumulated Depreciation & Amortization at -$1.7 million for Q1 2026, down 930.0% from a year ago — trailing twelve months through Mar 2026 was -$1.7 million (down 930.0% YoY), and the annual figure for FY2025 was -$1.6 million, down 423.9%.
  • Accumulated Depreciation & Amortization reached -$1.7 million in Q1 2026 per ANRO's latest filing, down from -$1.6 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $502000.0 in Q4 2024 and bottomed at -$1.7 million in Q1 2026.
  • Median Accumulated Depreciation & Amortization over the past 4 years was $200000.0 (2024), compared with a mean of -$176307.7.
  • The largest annual shift saw Accumulated Depreciation & Amortization soared 110.0% in 2024 before it plummeted 930.0% in 2026.
  • Over 4 years, Accumulated Depreciation & Amortization stood at $400000.0 in 2023, then grew by 25.5% to $502000.0 in 2024, then plummeted by 423.9% to -$1.6 million in 2025, then dropped by 2.09% to -$1.7 million in 2026.
  • Business Quant data shows Accumulated Depreciation & Amortization for ANRO at -$1.7 million in Q1 2026, -$1.6 million in Q4 2025, and -$1.5 million in Q3 2025.